Severe post-herpetic neuralgia successfully treated with botulinum toxin A: Three case reports

Acta Dermato-Venereologica

Volumn 89, Issue 2, 2009, Pages 214-215

  Sotiriou, Eleni ^a   Apalla, Zoe ^a   Panagiotidou, Despina ^a   Ioannidis, Demetris ^a  

^a ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

BOTULINUM TOXIN A;

ADULT; AGED; CASE REPORT; DISEASE DURATION; FEMALE; HERPES ZOSTER; HUMAN; INJECTION SITE ERYTHEMA; INJECTION SITE STINGING; LETTER; MALE; POSTHERPETIC NEURALGIA; PRIORITY JOURNAL; TREATMENT DURATION; VARICELLA ZOSTER VIRUS; VISUAL ANALOG SCALE;

AGED; BOTULINUM TOXIN TYPE A; FEMALE; HUMANS; MALE; MIDDLE AGED; NEURALGIA, POSTHERPETIC; NEUROMUSCULAR AGENTS; PAIN MEASUREMENT;

EID: 63049130988     PISSN: 00015555     EISSN: None     Source Type: Journal    
DOI: 10.2340/00015555-0609     Document Type: Letter

References (14)

1. Weinberg JM. Herpes zoster: epidemiology, natural history, and common complications. J Am Acad Dermatol 2007; 57: 130-135.
2. Ruiz Huete C, Bermejo PE. Botulinum toxin type A in the treatment of neuropathic pain in a case of postherpetic neuralgia. Neurologia 2008; 23: 259-262.
3. Liu HS, Tsai SK, Kao MC, Hu JS. Botulinum toxin A relieved neuropathic pain in a case of post-herpetic neuralgia. Pain Med 2006; 7: 89-91.
4. Klein AW. The therapeutic potential of botulinum toxin. Dermatol Surg 2004; 30: 452-455.
5. Dworkin RH, Gnann JW Jr, Oaklander AL, Raja SN, Schmader KE, Whitley RJ. Diagnosis and assessment of pain associated with herpes zoster and postherpetic neuralgia. J Pain 2008; 9: 37-44.
6. Kost RG, Strauss SE, Wood AJJ. Post herpetic neuralgia-pathogenesis, treatment, and prevention: a review article. N Engl J Med 1996; 4: 32-40.
7. Coderre TJ, Katz J, Vaccarino AL, Melzac R. Contribution of central neuroplasticity to pathological pain: review of the clinical and experimental evidence. Pain 1993; 52: 259-285.
8. Bennett GJ. Hypothesis on the pathogenesis of herpes zoster-associated pain. Ann Neurol 1994; 35: 38-41.
9. Woolf CJ, Shotland P, Coggeshall RE. Peripheral nerve injury triggers central sprouting of myelinated afferents. Nature 1992; 335: 75-78.
10. Cervero F, Laird JMA. Mechanisms of touch-evoked pain (allodynia): a new model. Pain 1996; 68: 132-133.
11. Sugeng MW, Yosipovitch G, Leok GC. Post herpetic neuralgia and the dermatologist. Int J Dermatol 2001; 40: 6-11.
12. Tyring SK. Management of herpes zoster and postherpetic neuralgia. J Am Acad Dermatol 2007; 57: 136-142.
13. Gnann JW Jr. Vaccination to prevent herpes zoster in older adults. J Pain 2008; 9: 31-36.
14. Blassi J, Chapman ER, Link E, Binz T, Yamasaki S, Camilli P, et al. Botulinum neurotoxin A selectively cleaves the synaptic protein SNAP-25. Nature 1993; 365: 160-163.